RecruitingNCT07102823

Clinical Registry for the Characterization of the 'Pulmonary Vascular Phenotype' in Patients With Chronic Obstructive Pulmonary Disease

Clinical Registry for the Characterization of the 'Pulmonary Vascular Phenotype' in Patients With Chronic Obstructive Pulmonary Disease - a Retrospective Multi-center Data Analysis


Sponsor

Medical University of Graz

Enrollment

1,000 participants

Start Date

Sep 1, 2025

Study Type

OBSERVATIONAL

Conditions

Summary

Registry of COPD (Chronic Obstructive Pulmonary Disease) patients who underwent right heart catheterization (RHC) and full clinical evaluation for pulmonary hypertension


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This registry study is collecting detailed information on how COPD (chronic obstructive pulmonary disease) affects blood vessels in the lungs — a condition called pulmonary vascular disease — in order to better understand this overlap and how to treat it. **You may be eligible if...** - You are 18 or older - You have a clinical diagnosis of COPD - You have undergone a right heart catheterization (a procedure to measure pressure in the heart and lung blood vessels) **You may NOT be eligible if...** - You are under 18 - You have not been diagnosed with COPD - You have not had a right heart catheterization Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(3)

Medical University of Graz

Graz, Austria

University of Zurich

Zurich, Switzerland

University of Sheffield

Sheffield, United Kingdom

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07102823


Related Trials